AngioSoma, Inc. SOAN OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

14/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

AngioSoma, Inc. (SOAN) reported total assets of $89.91K and total liabilities of $749.13K for fiscal year 2020, resulting in total equity of $-659.22K.

The company held $81.44K in cash and short-term investments. Total debt stood at $59.65K, with net debt of $-21.79K. The Debt-to-Equity (D/E) ratio was -0.09 (conservative).

Current ratio is 0.12, which may signal tight short-term liquidity. Interest coverage is -1.3x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (0/100) — Total assets $89.91K and equity $-659.22K support the company's competitive scale

Overall SharesGrow Score: 13/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

14/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

0/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

AngioSoma, Inc. Balance Sheet History

Metric	FY2020	FY2019	FY2018	FY2017
Total Assets	$89.91K	$142.18K	$124.75K	$24.55K
Total Liabilities	$749.13K	$827.62K	$995.48K	$648.53K
Total Debt	$59.65K	$173.45K	$344.93K	$148.44K
Cash & Investments	$81.44K	$100.46K	$91.6K	$14.1K
Total Stockholders Equity	$-659.22K	$-685.44K	$-870.73K	$-623.98K